What if one answer to treating cancer was not a blockbuster drug but a way of boosting the immune system to kill tumours and stop them from spreading?
A UK-based bioscience company will test that novel approach in clinical trials set to begin in Ireland next year, saying it offers hope to patients for whom other therapies have failed.
Lift BioSciences, whose chair Antonin de Fougerolles helped develop the mRNA technology Moderna used in its Covid-19 vaccines, believes it could have its treatment on the market by the end of the decade.
您已阅读15%（538字），剩余85%（3063字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。